Thank you, Mr. Chair. I'll be sharing my time with Mr. Fanjoy.
My question for Ms. Robinson refers to the H5N1 vaccines in particular.
Now that we've experienced the 2021 outbreak, gotten through it and seen our procurement of vaccines, what improvements have already been made to procurement tracking and distribution processes since the audit period closed? Are we on track to implement system-level updates at any point in the coming year?